ADEOYE OLUKOTUN - 10 Jun 2024 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris, Attorney-in-Fact
Issuer symbol
TNXP
Transactions as of
10 Jun 2024
Net transactions value
-$1.55
Form type
4
Filing time
28 Feb 2025, 17:31:25 UTC
Previous filing
24 May 2024
Next filing
20 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock, par value $0.001 Other $1.55 -1 -100% $1.91 0 10 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock.